Teneligliptin Impurities Now Available Ready Stock in KarpsChem

Teneligliptin hydrobromide hydrate was approved by Pharmaceuticals and Medicals Devices Agency of Japan (PMDA) on June 29, 2012. It was co-developed & co-marketed as Tenelia® by Mitsubishi Tanabe and Daiichi Sankyo. Teneligliptin hydrobromide hydrate is a dipeptidyl peptidase-4 inhibitor. It is indicated for the treatment of type 2 diabetes. Tenelia® is available as tablet for oral use, […]

... Read More.

KarpsChem Recent Impurity Development Update: October

Variety of impurities like Genotoxic, Neurotoxic impurities required for agencies like USFDA, MHRDA etc,are available. KarpsChem specialized in manufacturing and supply of pharmacopoeia impurities, process impurities, isolation and identification of unknown impurities. KarpsChem is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Guaifenesin, pharmacopeial and non-pharmacopeial Guaifenesin impurities, metabolites, stable […]

... Read More.